Pharmacogenomics studies how human genetic information impacts drug response. Rapid advances in our understanding of this area mean we now know that genetic differences between individuals can affect everything from the drug or drug class most likely to provide benefit to the likelihood of drug toxicity.

发言人:: James M. Beck Matthew D. Jacobson

活动类型: 继续法律教育(CLE)或继续专业发展(CPD), 网络研讨会

开始日期/时间:
5 April 2018, 3:00 PM EDT
结束日期/时间:
5 April 2018, 4:00 PM EDT
This webinar will discuss how pharmacogenomics is already affecting product liability litigation and what further impact could be just around the corner.